2025. 09.24-26
上海世博展览馆1号馆&2号馆

2026. 9.1-9.3

Shanghai New InternationalExpo Center, N1-N4

Exhibition in

Days

Cardiovascular disease affects a large global patient population and involves diagnosis, monitoring, surgery, and long-term treatment. This creates demand for a broad range of cardiovascular medical devices. Medtec China 2026, to be held from September 1 to 3 at the Shanghai New International Expo Centre, offers industry professionals focusing on the cardiovascular medical device market a centralized platform to review upstream suppliers and related technologies. 

Applications for free admission are now open. Industry professionals can register in advance and plan their visit to review suppliers, products, and technologies, identify potential partners, and explore solutions to business development challenges.

free ticket for the Medtec China 2026

Global Cardiovascular Disease Burden & Medical Device Demand

Data source:
2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association, Circulation (2026), based on estimates from the 2021 Global Burden of Disease study

These figures point to a sizeable, sustained demand base for cardiovascular medical devices used in prevention, diagnosis, monitoring, and treatment. In many health systems, this demand interacts with limited budgets and workforce capacity, bringing device reliability, supply continuity, and total cost of ownership into sharper focus. Within this context, Medtec China 2026 offers a practical setting to examine sourcing options and technical solutions, including those specific to cardiovascular technologies, in a single venue.

Learn how to apply for a free ticket: Free Tickets Open for 2026 Medtec

Medtec China 2026 scale
Medtec China 2026

Global Cardiovascular Medical Device Market Trends & Regional Insights

Published market estimates vary because research firms use different product definitions, geographic coverage, and forecast periods. Fortune Business Insights indicates that the global cardiovascular medical device market was valued at USD 70.02 billion in 2025 and is projected to grow at a CAGR of 8.07% from USD 74.88 billion in 2026 to USD 139.35 billion by 2034.[1]

Regional Market Highlights

Region/CountryMarket Highlights
United States/North AmericaNorth America holds the largest share of cardiovascular devices revenue, supported by high utilization of interventional cardiology and rhythm management procedures.
EuropeEurope shows steady demand with a strong focus on clinical evidence, cost-effectiveness, and structured procurement frameworks.
ChinaChina is one of the faster-growing markets; the China coronary stents market, for example, is projected to grow at about 6.9 percent CAGR from 2024 to 2030.[2]
JapanJapan is a mature market with high cardiovascular disease prevalence in older adults and continued use of minimally invasive and monitoring-related cardiovascular medical devices.

Important and frequently discussed cardiovascular device categories include drugeluting and bioresorbable coronary stents, transcatheter valve systems, cardiac rhythm management devices, peripheral vascular devices, and diagnostic and monitoring systems. In China, NMPA fasttrack approvals for coronary stents, TAVR systems, and pulsed field ablation equipment demonstrate active development in cardiovascular technologies.

These patterns indicate that the cardiovascular medical device market remains competitive and technology-driven across major regions.

You may also be interested in: Top 10 Surgical Robot Companies in 2026

Cardiovascular Medical Device Supply Chain & Sourcing Challenges

A typical cardiovascular medical device moves through several stages:

R&D stage of cardiovascular medical device

Key challenges include price pressure from centralized procurement programs; evolving regulatory standards; and the need for qualified suppliers that can support multi‑country registrations and audits. Uncoordinated sourcing decisions can lead to delays, higher lifecycle costs, or compliance issues for cardiovascular medical device companies.

Medtec China 2026 organizes exhibits by product theme, covering materials and core components, precision manufacturing, active medical equipment, IVD and drug delivery, OEM/ODM and automation, packaging and sterilization, R&D and regulatory services, and testing and quality. This structure aligns well with the medical device supply chain and allows visitors working in cardiovascular technologies to map suppliers to each stage of development and manufacturing.

Explore how Medtec China supports innovation across the medical device supply chain: Medtec China 2026: Innovating the Medical Device Supply Chain

Cardiovascular industry professionals may wish to prioritize:

Medical-grade metals, polymers & coatings: Focus on Hall N1 & N2 for materials used in stents, heart valves, guidewires and other implantable cardiovascular devices.
Precision tubing, extrusion & ultra-fine wires: Explore Hall N1 & N2 for catheter tubing, guidewire components and precision manufacturing technologies.
Sensors, electronics & active medical technologies: Visit Hall N1 for components supporting cardiac monitoring, electrophysiology and minimally invasive cardiovascular procedures.
OEM/ODM & Smart Manufacturing: Visit Hall N3 for contract manufacturing, production automation and smart factory solutions.
Packaging, sterilization, cleanroom & quality testing: Explore Hall N4 for sterile packaging, sterilization, cleanroom systems, inspection and regulatory compliance solutions.

These categories correspond directly to practical sourcing needs for cardiovascular medical device companies, whether serving domestic markets or exporting to the United States, Europe, Japan, and other regions.

Medtec China 2026 exhibition hall categories and floor plan

Key Information and Activities at Medtec China 2026

To assist with visit planning, the key information for Medtec China 2026 is provided below:

Explore potential technical partners in advance by browsing the official Medtec China 2026 Exhibitor List

The Medtec Global Medical Supply Chain Summit and related conferences cover:

The summit takes place during the three-day exhibition and is open freely to Medtec visitors.

Learn more about Medtec China: Medtec China: Uniting Medical Device R&D and Global Manufacturing

Conclusion

The global cardiovascular disease burden creates demand across diagnostic, interventional, surgical, and monitoring products. Market forecasts also indicate investment in established devices and newer cardiovascular technologies.

Companies participating in the cardiovascular medical device market need reliable partners for the medical device supply chain. Medtec China 2026 brings together suppliers and service providers across materials, components, production equipment, contract manufacturing, testing, packaging, sterilization, and compliance.

For teams with active sourcing or product development projects, registering in advance, reviewing exhibitor information, and scheduling supplier meetings beforehand can help improve the efficiency of their visit. Free tickets are available for registrations submitted by August 30, and industry professionals are welcome to register in advance.

References:

[1] Cardiovascular Devices Market Size, Share & Industry Analysis. Available at: https://www.fortunebusinessinsights.com/cardiovascular-devices-market-102418

[2] China Coronary Stents Market (2024 – 2030). Available at: https://www.grandviewresearch.com/industry-analysis/china-coronary-stents-market-report